Your browser doesn't support javascript.
loading
Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer.
Azizi, Nawab; Toma, Jelena; Martin, Mickenzie; Khalid, Muhammad Faran; Mousavi, Fatemeh; Win, Phyo Wei; Borrello, Maria Teresa; Steele, Nina; Shi, Jiaqi; di Magliano, Marina Pasca; Pin, Christopher L.
Affiliation
  • Azizi N; Children's Health Research Institute, London, ON, Canada.
  • Toma J; Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada.
  • Martin M; Children's Health Research Institute, London, ON, Canada.
  • Khalid MF; Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada.
  • Mousavi F; Department of Oncology, University of Western Ontario, London, ON, Canada.
  • Win PW; Children's Health Research Institute, London, ON, Canada.
  • Borrello MT; Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada.
  • Steele N; Department of Biology, University of Western Ontario, London, ON, Canada.
  • Shi J; Children's Health Research Institute, London, ON, Canada.
  • di Magliano MP; Department of Paediatrics, University of Western Ontario, London, ON, Canada.
  • Pin CL; Children's Health Research Institute, London, ON, Canada.
Oncogene ; 40(17): 3118-3135, 2021 04.
Article in En | MEDLINE | ID: mdl-33864001

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Activating Transcription Factor 3 Limits: Animals / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Activating Transcription Factor 3 Limits: Animals / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Canada